date name shares transaction value  christine a pellizzari general counsel  corp sec    acquisition at  per share   christine a pellizzari general counsel  corp sec    acquisition at  per share   melvin sharoky director    award at  per share   steinar johan engelsen director    award at  per share   donald j hayden director    award at  per share   david richard brennan director    award at  per share   alfred f altomari director    award at  per share   david w j mcgirr director    award at  per share   myrtle s potter director    award at  per share   andrew t drechsler chief financial officer    derivativenonderivative trans at  per share   andrew t drechsler chief financial officer    derivativenonderivative trans at  per share   andrew t drechsler chief financial officer    disposition at  per share   christine a pellizzari general counsel  corp sec    acquisition at  per share   christine a pellizzari general counsel  corp sec    acquisition at  per share   myrtle s potter director    disposition at  per share   myrtle s potter director    disposition at  per share   andrew t drechsler chief financial officer    derivativenonderivative trans at  per share   andrew t drechsler chief financial officer    disposition at  per share   andrew t drechsler chief financial officer    disposition at  per share   andrew t drechsler chief financial officer    derivativenonderivative trans at  per share   andrew t drechsler chief financial officer    derivativenonderivative trans at  per share   s nicole schaeffer svp hr  corp svcs    disposition at  per share   s nicole schaeffer svp hr  corp svcs    derivativenonderivative trans at  per share  newslatestcompanyusinsm marketwatch news on insm sp  nails first support dow industrials retest the day average  am may    michael ashbaugh insmed shares drop after european drugmarketing application withdrawn  pm june    wallace witkowski arikace gets fda fasttracks for lung treatments  am july    marketwatchcom insiders have been buying these stocks  pm jan    insider monkey insmed to sell  mln shares to investment firms  am sept    marketwatchcom insmed rockets on fda update  am may    val brickates kennedy insmed fda lifts halt on lungdiseasedrug trial  am jan    marketwatchcom stocks to watch tuesday netflix insmed  pm oct    david b wilkerson monday’s biggest gaining  declining stocks  pm oct    sue chang insmed fda extends halt to study seeks more data  am oct    marketwatchcom insmed tanks on fda study halt  pm aug    val brickates kennedy fda halts inmed study after rat tests  am aug    marketwatchcom newsnonmarketwatchcompanyusinsm other news on insm insmed insm investor presentation  slideshow  am july    seeking alpha implied volatility surging for insmed inc insm stock options  am july    zackscom options traders expect huge moves in insmed insm stock  am june    zackscom insmed names key additions to executive team  pm may    seeking alpha best biotech stocks for capital gains in the next  months  pm may    seeking alpha insmeds insm ceo will lewis on q  results  earnings call transcript  pm may    seeking alpha q insmed inc  am may    edgar online  edg  q k implied volatility surging for insmed insm stock options  am april    zackscom do options traders know something about insmed incorporated insm stock we dont  am march    zackscom insmeds insm ceo will lewis on q  results  earnings call transcript  pm feb    seeking alpha insmed reports q and fy results  am feb    seeking alpha k insmed inc  am feb    edgar online  edg  q k watch these  huge put purchases in tuesday trade  am feb    benzingacom insmed insm presents at th annual jp morgan healthcare conference  pm jan    seeking alpha matinas biopharma registers shares prepares for critical trials  pm nov    seeking alpha insmeds insm ceo will lewis on q  results  earnings call transcript  pm nov    seeking alpha q insmed inc  am nov    edgar online  edg  q k insmed inks license deal with astrazeneca for pulmonary disease candidate azd  am oct    seeking alpha q insmed inc  am aug    edgar online  edg  q k insmed withdraws arikayce marketing application in europe shares down  premarket  am june    seeking alpha loading more headlines at a glance insmed inc building   finderne avenue bridgewater new jersey  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for insm newspressreleasecompanyusinsm press releases on insm insmed to host analyst and investor day on july    am july    globenewswire insmed to present at the jmp securities life sciences conference  am june    globenewswire insmed reports inducement grants under nasdaq listing rule c  am june    globenewswire insmed announces key additions to its executive management team  am may    globenewswire insmed reports first quarter  financial results and provides business update  am may    globenewswire investor network insmed incorporated to host earnings call  am may    accesswire insmed to present at the deutsche bank nd annual health care conference  am april    globenewswire insmed to host first quarter  financial results conference call on wednesday may    am april    globenewswire insmed to present at the cowen and company th annual health care conference  am feb    globenewswire insmed reports fourth quarter  financial results and provides business update  am feb    globenewswire insmed to host fourth quarter and yearend  financial results conference call on thursday february    am feb    globenewswire insmed inc extends arikayce intellectual property protection with issuance of new us patent  am feb    globenewswire lifshitz  miller law firm announces investigation of calamos asset management inc cdi corp comscore inc earthstone energy inc heritage oaks bancorp insmed incorporated oci partners lp and vascular solutions inc  pm jan    pr newswire  prf insmed to present at the th annual jp morgan healthcare conference  am jan    globenewswire insmed to participate at november investor conferences  am nov    globenewswire robbins arroyo llp is investigating the officers and directors of insmed inc insm on behalf of shareholders  pm nov    businesswire  bzx insmed reports third quarter  financial results and provides business update  am nov    globenewswire insmed to host third quarter  financial results conference call on thursday november    am oct    globenewswire insmed announces publication of phase  study of arikayce in treatmentrefractory nontuberculous mycobacterial lung disease  am oct    globenewswire insmed announces worldwide license agreement with astrazeneca for oral dpp inhibitor  am oct    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest athe cracked benchmark why some investors want a new standard for bonds a moneymaking lessons from the richest man who ever lived age’s stock falls as jeff immelt’s th and last quarter is another disappointment anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix aalphabet earnings a  billion hit for google potential youtube results for investors amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat atrump says he has ‘complete power to pardon’ achipotle earnings media coverage of the latest illness scare will put earnings targets at risk aexxon earnings will stock trade higher on expected secondquarter beat apay tv expected to lose more than a million subscribers in latest quarter aqualcomm’s issues go beyond apple fight ayogaworks ipo pulled on valuation concerns not market conditions aamazon’s foray into groceries means more mergers of food companies experts say athis is what should really worry you about stocks aeuro rally has room to run if this pattern continues to hold true aweekend roundup companies that may cut dividends  faang stocks and market bubbles  enjoy london on the cheap aattention shoppers ‘amazon effect’ is creating bargain stocks awhy you might want to avoid these  dividend stocks astocks brace for volatility in earnings deluge fed meeting looms a charts that capture how the rest of the world feels about donald trump loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  news releases  insmed select page video player    use updown arrow keys to increase or decrease volume news releases all years                 update   jul   insmed to host analyst and investor day on july   view html  download pdf jun   insmed to present at the jmp securities life sciences conference view html  download pdf jun   insmed reports inducement grants under nasdaq listing rule c view html  download pdf may   insmed announces key additions to its executive management team view html  download pdf may   insmed reports first quarter  financial results and provides business update view html  download pdf apr   insmed to present at the deutsche bank nd annual health care conference view html  download pdf apr   insmed to host first quarter  financial results conference call on wednesday may   view html  download pdf feb   insmed to present at the cowen and company th annual health care conference view html  download pdf feb   insmed reports fourth quarter  financial results and provides business update view html  download pdf feb   insmed to host fourth quarter and yearend  financial results conference call on thursday february   view html  download pdf feb   insmed inc extends arikayce intellectual property protection with issuance of new us patent view html  download pdf jan   insmed to present at the th annual jp morgan healthcare conference view html  download pdf nov   insmed to participate at november investor conferences view html  download pdf nov   insmed reports third quarter  financial results and provides business update view html  download pdf oct   insmed to host third quarter  financial results conference call on thursday november   view html  download pdf oct   insmed announces publication of phase  study of arikayce in treatmentrefractory nontuberculous mycobacterial lung disease view html  download pdf oct   insmed announces worldwide license agreement with astrazeneca for oral dpp inhibitor view html  download pdf sep   insmed appoints roger adsett as chief commercial officer view html  download pdf sep   insmed to participate at september investor conferences view html  download pdf aug   insmed announces upcoming presentations at european respiratory society  international congress view html  download pdf aug   insmed reports second quarter  financial results view html  download pdf jun   insmed announces withdrawal of marketing authorization application for arikayce™ in europe view html  download pdf may   insmed to present at the bank of america global healthcare conference view html  download pdf may   insmed reports first quarter  financial results view html  download pdf may   insmed announces upcoming presentations at the american thoracic society  international meeting view html  download pdf mar   insmed to present at the th annual cowen  company healthcare conference view html  download pdf feb   insmed reports fourth quarter  financial results view html  download pdf jan   insmed to present at the th annual jp morgan healthcare conference view html  download pdf nov   insmed to present at the piper jaffray th annual healthcare conference view html  download pdf nov   insmed to present at the stifel  healthcare conference view html  download pdf nov   insmed reports third quarter  financial results and provides business update view html  download pdf oct   insmed to host third quarter  financial results conference call on friday november   view html  download pdf oct   insmed announces upcoming data presentation at amcp nexus  view html  download pdf oct   the balancing actr on lifetime to feature ntm lung disease view html  download pdf oct   insmed launches comprehensive educational campaign to raise awareness of ntm lung disease view html  download pdf oct   insmed announces upcoming data presentations at infectious disease week  view html  download pdf sep   insmed to present at the leerink partners rare disease roundtable view html  download pdf sep   insmed announces upcoming data presentations at ers  view html  download pdf sep   insmed announces upcoming data presentations at icaacicc  view html  download pdf aug   insmed reports second quarter  financial results and provides business update view html  download pdf jul   insmed to host second quarter  financial results conference call on thursday august   view html  download pdf jun   insmed to participate at the jmp securities life sciences conference view html  download pdf may   insmed announces upcoming data presentations at the american thoracic society  international meeting view html  download pdf may   insmed to participate at the ubs global healthcare conference view html  download pdf may   insmed reports first quarter  financial results view html  download pdf apr   insmed announces closing of public offering and exercise of option to purchase additional shares view html  download pdf mar   insmed announces pricing of public offering of common stock view html  download pdf mar   insmed announces proposed public offering of common stock view html  download pdf mar   insmed reports inducement grants under nasdaq listing rule c view html  download pdf mar   insmed appoints dr eugene sullivan as chief medical and scientific officer view html  download pdf feb   insmed reports  fourth quarter and full year financial results view html  download pdf feb   insmed to participate at cowen  companys th annual health care conference view html  download pdf jan   insmed to participate at february investment conferences view html  download pdf jan   insmed incorporated reports inducement grants under nasdaq listing rule c view html  download pdf jan   insmed to present at the rd annual jp morgan healthcare conference view html  download pdf dec   insmed appoints myrtle potter to its board of directors view html  download pdf dec   insmed provides end of year regulatory and clinical update view html  download pdf nov   insmed to participate at december investment conferences view html  download pdf nov   insmed reports third quarter  financial results view html  download pdf oct   insmed to host third quarter  financial results conference call on thursday november   view html  download pdf sep   insmed to participate in leerink partners rare disease roundtable view html  download pdf sep   insmed to present at the rodman  renshaw annual global investment conference view html  download pdf sep   insmed announces multiple clinical and scientific presentations at european respiratory societys international congress  view html  download pdf aug   insmed announces closing of public offering and exercise of option to purchase additional shares view html  download pdf aug   insmed announces pricing of public offering of common stock view html  download pdf aug   insmed announces proposed public offering of common stock view html  download pdf aug   insmed reports second quarter  financial results view html  download pdf aug   insmed provides regulatory update for arikayce view html  download pdf jun   insmed to present at the jmp securities healthcare conference view html  download pdf may   insmed appoints david r brennan to its board of directors view html  download pdf may   insmed announces positive open label data from phase  clinical trial of arikayce for treatment resistant nontuberculous mycobacterial lung infections view html  download pdf may   insmed announces data presentations for arikayce in two orphan lung diseases at the american thoracic society meeting view html  download pdf may   insmed to participate in the bank of america merrill lynch  health care conference view html  download pdf may   insmed reports first quarter  financial results view html  download pdf apr   insmed to participate in the th annual needham  co healthcare conference view html  download pdf apr   insmed announces leadership team transitions and appointments to expand support for growth opportunities view html  download pdf mar   insmed announces results from phase  clinical trial for treatment resistant nontuberculous mycobacterial lung infections view html  download pdf mar   insmed to announce results from us phase  clinical trial for treatment resistant nontuberculous mycobacteria lung infections view html  download pdf mar   insmed reports  fourth quarter and full year financial results view html  download pdf feb   insmed provides interim update from twoyear openlabel extension study of arikace to treat pseudomonas aeruginosa in cystic fibrosis patients  download pdf feb   arikace to receive orphan medicinal product designation in the european union to treat lung infections caused by nontuberculous mycobacteria view html  download pdf feb   insmed to present at the leerink swann global healthcare conference view html  download pdf nov   insmed reports third quarter  financial results view html  download pdf nov   insmed appoints david wj mcgirr to its board of directors view html  download pdf oct   insmed to host third quarter  financial results conference call on tuesday november   view html  download pdf oct   insmed completes enrollment of phase  clinical trial of arikace to treat nontuberculous mycobacteria lung disease in us and canada view html  download pdf sep   insmed to present at leerink swann rare disease roundtable view html  download pdf sep   insmed fortifies global patent portfolio view html  download pdf sep   insmed to participate in the stifel healthcare conference  view html  download pdf aug   insmed to participate in august investor conferences view html  download pdf aug   insmed reports second quarter financial results view html  download pdf jul   insmed to host second quarter  financial results conference call on tuesday august   view html  download pdf jul   insmed appoints christine pellizzari as general counsel and corporate secretary view html  download pdf jul   insmed announces closing of public offering and exercise of option to purchase additional shares view html  download pdf jul   insmed announces pricing of public offering of common stock view html  download pdf jul   insmed announces proposed public offering of common stock view html  download pdf jul   insmed to present at the th annual jmp securities healthcare conference view html  download pdf jul   arikace meets primary endpoint of noninferiority to tobi in phase  clinical trial in europe and canada to treat pseudomonas aeruginosa in cystic fibrosis patients view html  download pdf jun   insmed to report topline results from phase  clinical trial of arikace to treat pseudomonas aeruginosa in cystic fibrosis view html  download pdf jun   insmed to join the russell globalr and russell r indexes view html  download pdf may   insmed granted key composition of matter patent allowance for arikace in europe view html  download pdf may   insmed to present at the ubs global healthcare conference view html  download pdf may   insmed to present at the bank of america merrill lynch  health care conference view html  download pdf may   insmed reports first quarter financial results view html  download pdf may   insmed to host first quarter  financial results conference call on tuesday may   view html  download pdf apr   insmed to present at the th annual needham healthcare conference view html  download pdf apr   insmed appoints matthew pauls as chief commercial officer view html  download pdf mar   arikace receives orphan drug designation for treating infections caused by nontuberculous mycobacteria view html  download pdf mar   insmed to present at future leaders in the biotech industry conference view html  download pdf mar   insmed reports fourth quarter and full year  financial results view html  download pdf mar   insmed to host fourth quarter and full year  financial results conference call on monday march   view html  download pdf feb   insmed to present at two upcoming investor conferences view html  download pdf feb   insmed to present at two upcoming healthcare investor conferences view html  download pdf dec   insmed to present at st annual jp morgan healthcare conference view html  download pdf nov   insmed announces clear phase  clinical study of arikace® in cystic fibrosis patients with pseudomonas lung infections has completed target enrollment view html  download pdf nov   insmed to present at two upcoming investor conferences view html  download pdf nov   insmed announces financial results for third quarter and ninemonths ended september   view html  download pdf nov   insmed appoints year life sciences industry veteran andrew drechsler as chief financial officer view html  download pdf oct   insmed to host  third quarter earnings conference call view html  download pdf sep   insmed announces pricing of approximately  million direct public offering view html  download pdf sep   insmed appoints will lewis as president and chief executive officer view html  download pdf aug   insmed to present at stifel nicolaus  healthcare conference view html  download pdf aug   insmed to present at  wedbush pacgrow life sciences management access conference view html  download pdf aug   insmed announces financial results for second quarter and sixmonths ended june   view html  download pdf aug   pharmaceutical industry veteran al altomari elected to insmeds board of directors view html  download pdf aug   insmed receives second composition of matter patent for arikace® view html  download pdf jul   insmed announces planned departure of chief financial officer view html  download pdf jul   insmed to host  second quarter earnings conference call view html  download pdf jul   insmed to present at jmp securities th annual healthcare conference view html  download pdf jul   insmed secures  million loan agreement with hercules technology growth capital view html  download pdf jun   insmed announces first patient dosed in targetntm phase  clinical trial of arikace® in patients with nontuberculous mycobacteria ntm lung disease view html  download pdf may   insmed provides corporate update view html  download pdf may   insmed incorporated begins screening patients for targetntm us clinical trial of arikace® in patients with nontuberculous mycobacterial lung disease view html  download pdf may   insmed appoints donald j hayden jr as executive chairman view html  download pdf may   insmed announces first quarter  financial results view html  download pdf may   insmed incorporated announces lifting of clinical hold by us food and drug administration on arikace® in cystic fibrosis patients with pseudomonas lung infections view html  download pdf apr   insmed to host  first quarter earnings conference call view html  download pdf apr   insmed announces first patient dosed in pivotal european phase  clinical study of arikace® in cystic fibrosis patients with pseudomonas lung infections view html  download pdf mar   insmed announces fourth quarter and fullyear  financial results view html  download pdf feb   insmed to host fourth quarter and  yearend earnings conference call view html  download pdf feb   insmed incorporated provides update on clinical program for arikace® view html  download pdf jan   insmed incorporated provides corporate update view html  download pdf nov   insmed to present at lazard capital markets th annual healthcare conference view html  download pdf nov   insmed announces financial results for third quarter and ninemonths ended september   view html  download pdf oct   insmed to host  third quarter earnings conference call view html  download pdf oct   insmed incorporated provides regulatory update on arikace® in nontuberculous mycobacteria indication view html  download pdf oct   insmed incorporated provides regulatory update view html  download pdf sep   insmed to present at sixth annual jmp securities healthcare conference view html  download pdf aug   insmed to present at  wedbush securities life sciences management access conference view html  download pdf aug   insmed announces financial results for second quarter and sixmonths ended june   view html  download pdf aug   insmed incorporated announces clinical hold on arikace® phase  clinical trials view html  download pdf jul   insmed to host  second quarter earnings conference call view html  download pdf jul   andrea drucker joins insmed as general counsel view html  download pdf jun   insmed announces its addition to the russell ® index view html  download pdf jun   insmeds arikace® demonstrates sustained benefit through six cycles of treatment for cystic fibrosis patients with pseudomonas lung infections view html  download pdf may   insmed announces first quarter  financial results view html  download pdf apr   insmed to host  first quarter earnings conference call view html  download pdf mar   insmed announces fda clearance of ind for pivotal phase  trial of arikace™ in nontuberculous mycobacteria indication view html  download pdf mar   insmed regains nasdaq compliance view html  download pdf mar   insmed announces fourth quarter and fullyear  financial results view html  download pdf mar   insmed announces european medicines agency acceptance of its pediatric investigation plan for arikace™ in the cystic fibrosis pseudomonas indication view html  download pdf mar   onefor reverse stock split of insmed common stock becomes effective view html  download pdf mar   insmed shareholders approve conversion of series b conditional convertible preferred stock and reverse stock split view html  download pdf feb   insmed to participate on phase iii and beyond panel at  rbc capital markets healthcare conference view html  download pdf feb   insmed to host fourth quarter and  yearend earnings conference call view html  download pdf dec   nasdaq grants insmed incorporated day extension to regain compliance with minimum bid price rule view html  download pdf dec   insmed incorporated and transave inc announce business combination view html  download pdf nov   insmed announces financial results for third quarter and ninemonths ended september   view html  download pdf oct   insmed to host third quarter  conference call view html  download pdf aug   insmed announces financial results for second quarter and sixmonths ended june   view html  download pdf jul   insmed to host second quarter  conference call view html  download pdf jun   insmed receives nasdaq deficiency notice relating to minimum bid price view html  download pdf may   insmed announces first quarter  financial results view html  download pdf apr   insmed to host first quarter  conference call view html  download pdf mar   pharmaceutical industry veteran nicholas labella jr ms rph joins insmed as chief scientific officer view html  download pdf mar   insmed announces fourth quarter and fullyear  financial results view html  download pdf mar   insmed regains nasdaq compliance view html  download pdf mar   insmed to host fourth quarter and fullyear  conference call view html  download pdf nov   insmed announces financial results for third quarter and ninemonths ended september   view html  download pdf oct   insmed to host third quarter  conference call view html  download pdf sep   insmed receives nasdaq deficiency notice relating to minimum bid price view html  download pdf aug   insmed announces financial results for second quarter and sixmonths ended june   view html  download pdf jul   insmed to host second quarter  conference call view html  download pdf jul   insmed provides update on supply of iplextm view html  download pdf jun   insmed announces addition to the russell r index view html  download pdf jun   insmed announces results of iplextm phase ii trial in myotonic muscular dystrophy view html  download pdf jun   insmed ceo resigns due to health concerns view html  download pdf may   insmed announces first quarter  financial results view html  download pdf may   insmed regains nasdaq compliance view html  download pdf apr   insmed to host first quarter  conference call view html  download pdf mar   insmed completes sale of followon biologics platform to merck  co inc for gross proceeds of  million view html  download pdf mar   insmed announces agreement with idis to manage expanded access programs for iplextm view html  download pdf mar   insmed announces that nasdaq further extends temporary suspension of minimum bid closing price rule view html  download pdf mar   insmed announces fourth quarter and fullyear  financial results view html  download pdf mar   insmed announces fda issues statement regarding position on allowing patients with als access to iplextm under an ind view html  download pdf feb   insmed to host fourth quarter and fullyear  conference call view html  download pdf feb   insmed sells followon biologics platform to merck  co inc for gross proceeds of  million view html  download pdf jan   insmed and premacure announce european orphan designation for iplextm in retinopathy of prematurity in infants view html  download pdf dec   insmed announces that nasdaq extends temporary suspension of minimum bid closing price rule view html  download pdf nov   insmed to present at sanford c bernstein biosimilars long view conference view html  download pdf nov   insmed to participate in federal trade commission roundtable on followon biologic drugs framework for competition and continued innovation view html  download pdf nov   insmed gains royaltyfree worldwide rights for iplextm in connection with potential expanded access als programs view html  download pdf nov   insmed to present at upcoming healthcare conferences view html  download pdf oct   insmed announces financial results for third quarter and ninemonths ended september   view html  download pdf oct   nasdaqs temporary suspension of minimum bid closing price rules extends insmeds compliance date to march   view html  download pdf oct   insmed announces that nasdaq temporarily suspends minimum bid closing price rule view html  download pdf oct   insmed to host third quarter  conference call view html  download pdf oct   insmed initiates clinical study for followon biologic version of neulastar view html  download pdf oct   insmed to seek shareholder approval for reverse split view html  download pdf sep   insmed and premacure cite study results demonstrating potential effectiveness of iplextm in preventing blindness in premature infants view html  download pdf sep   insmed to present at biosimilars  conference view html  download pdf sep   insmed to present at biopharm asia  conference view html  download pdf sep   nasdaq hearing panel grants insmed request for continued listing on the nasdaq stock market view html  download pdf aug   insmed announces financial results for second quarter and sixmonths ended june   view html  download pdf jul   jim miller phd joins insmed therapeutic proteins as vice president of process development view html  download pdf jul   insmed to host second quarter  conference call view html  download pdf jul   insmed ceo to present at drug discovery  development conference view html  download pdf jul   insmed ceo to present at congressional briefing on followon biologics view html  download pdf jul   insmed provides update on iplextm programs view html  download pdf jul   insmed partners with bill thomas former house ways and means chairman as strategic advisor view html  download pdf jul   insmed retains rbc capital markets as strategic financial advisor view html  download pdf jul   insmed announces first human bioequivalence data for a followon biologic by a us company view html  download pdf jul   insmed to present at collins stewart fourth annual growth conference view html  download pdf jun   insmed to request hearing before nasdaq panel to review nasdaq staff determination view html  download pdf may   c o r r e c t i o n  insmed inc view html  download pdf may   insmed announces first quarter  financial results view html  download pdf apr   insmed provides update on followon biologics and iplextm programs view html  download pdf apr   insmed to host first quarter  conference call view html  download pdf apr   insmed to present at cbi followon biologics conference view html  download pdf apr   insmed initiates clinical study for followon biologic version of neupogenr view html  download pdf apr   insmed selected to complete congressional questionnaire regarding the potential establishment of a followon biologics regulatory pathway view html  download pdf mar   insmed announces additional information in compliance with nasdaq rules view html  download pdf mar   insmed announces fourth quarter and fullyear  financial results view html  download pdf feb   insmed announces listing transfer from nasdaq global market to nasdaq capital market view html  download pdf feb   insmed to host fourth quarter and fullyear  conference call view html  download pdf feb   study by leading economist identifies potential for  billion of savings from follow on biologics view html  download pdf feb   insmed launches national awareness campaign surrounding followon biologics view html  download pdf feb   insmed ceo issues statement on white house fy budget and fda statements on followon biologics view html  download pdf jan   insmed provides update on iplextm expanded access program in italy for the treatment of amyotrophic lateral sclerosis view html  download pdf jan   insmed completes external assessment of myotonic muscular dystrophy market view html  download pdf dec   insmed to appeal delisting notification from nasdaq view html  download pdf dec   insmed receives fda orphan drug designation for iplextm in the treatment of myotonic muscular dystrophy view html  download pdf dec   insmed awarded  million by muscular dystrophy association view html  download pdf dec   insmed appoints dennis m lanfear to board of directors view html  download pdf dec   insmed to present at the ibc th annual global followon biologics conference view html  download pdf dec   insmed retains fd and gibraltar associates for investor relations and corporate communications view html  download pdf nov   insmed advances follow on biologics initiative view html  download pdf nov   insmed reports financial results for third quarter and nine months ended september   view html  download pdf nov   insmed announces initiation of phase ii clinical trial with iplextm in myotonic muscular dystrophy view html  download pdf oct   insmed announces third quarter earnings release date and conference call view html  download pdf oct   insmed to present at the acumen biofin rodman  renshaw th annual healthcare conference view html  download pdf oct   insmed to present at the  bio investor forum on wednesday october   view html  download pdf aug   insmed reports financial results for second quarter and first half of  view html  download pdf jul   insmed announces second quarter and first half earnings release date and conference call view html  download pdf jul   insmed inc to present at ce unterberg towbin growth conference view html  download pdf jun   insmed inc welcomes studies linking igfbp to prevention of blindness in premature infants view html  download pdf jun   experienced biopharmaceutical executive steve glover joins insmed will lead development of followon biologics view html  download pdf jun   insmed receives nasdaq deficiency notice relating to minimum bid price view html  download pdf may   insmed incorporated reports financial results for first quarter ended march   view html  download pdf may   insmed announces first quarter earnings release date and conference call view html  download pdf may   insmed raises approximately  million in registered direct offering view html  download pdf may   insmed announces promising results from iplex phase ii myotonic muscular dystrophy clinical study view html  download pdf may   insmed ceo geoffrey allan testifies at energy and commerce committee hearing view html  download pdf apr   insmed releases positive results from iplex phase ii hivassociated adipose redistribution syndrome clinical study view html  download pdf apr   insmed inc releases investor fact sheet with updates on drug development progress view html  download pdf mar   insmed ceo geoffrey allan testifies at congressional hearing view html  download pdf mar   insmed announces additional information in compliance with nasdaq rules view html  download pdf mar   insmed inc reports financial results for fourth quarter and twelve months view html  download pdf mar   update insmed to hold  q and year end earnings results view html  download pdf mar   insmed to hold  q and year end earnings results view html  download pdf mar   insmed announces restructure settlement ending iplextm patent dispute view html  download pdf mar   insmed to discuss litigation settlement with tercica view html  download pdf jan   italian ministry of health requests iplextm for treatment of als lou gehrigs disease view html  download pdf dec   insmed announces positive iplextm product information at grsigf society meeting in kobe japan view html  download pdf dec   insmed to host litigation update conference call view html  download pdf dec   insmed patent litigation verdict announced view html  download pdf nov   insmed to present at upcoming investor conference in nyc view html  download pdf nov   insmed incorporated reports financial results for the third quarter and nine months ended september   view html  download pdf oct   insmed inc to announce  third quarter financial results view html  download pdf oct   jody lomenzo named director investor relations and corporate communications view html  download pdf oct   insmed to present at upcoming conferences view html  download pdf oct   former amgen manufacturing executive joins insmed view html  download pdf oct   insmed announces addition of top  patent lawyer to litigation team view html  download pdf oct   insmed to present at the bio investor forum meeting view html  download pdf oct   insmed sues tercica for false advertising view html  download pdf oct   insmed provides update concerning virginia unfair competition litigation view html  download pdf sep   insmed to present at the biocentury newsmakers in the biotech industry conference view html  download pdf aug   insmed incorporated reports financial results for the first half and second quarter ended june   view html  download pdf aug   insmed inc to webcast  second quarter financial results conference call tuesday august   at  pm et view html  download pdf jul   phyton biotech signs development agreement with insmed view html  download pdf jul   insmed inc to webcast  second quarter financial results conference call tuesday august   at  pm et view html  download pdf jul   insmed to present at the ce unterberg towbin emerging growth opportunities conference view html  download pdf jul   court decision means that patent dispute between insmed and tercica and genentch will have to be resolved at trial view html  download pdf jul   european medicines agency validates insmeds regulatory application for marketing iplextm in europe view html  download pdf jun   insmed presents positive iplextm data at endo  view html  download pdf jun   insmed endocrine society  update insmed will report efficacy of iplextm in patients with severe insulin resistance company also to present data on the unique pharmacokinetics of iplex view html  download pdf jun   court dismisses baseless unfair business practices lawsuit that was brought against insmed view html  download pdf jun   insmed provides update on iplextm launch company shares details on payer usage program and pricing view html  download pdf may   insmed announces iplextm availability nationwide for children with severe short stature iplex launch marked by the first product shipments to patients in states across the country view html  download pdf may   insmed incorporated to present at the rodman  renshaw rd annual healthcare conference view html  download pdf may   insmed incorporated reports financial results for the first quarter ended march   view html  download pdf may   insmed inc to webcast  first quarter financial results conference call monday may   at  pm et view html  download pdf may   iplextm demonstrates significant dosedependent increases in growth rate view html  download pdf apr   insmed announces podium presentation at the pediatric academic societies  annual meeting view html  download pdf apr   nord honors insmed for role in developing treatments for rare diseases view html  download pdf mar   insmed announces additional information in compliance with nasdaq rules view html  download pdf mar   insmed completes  million public offering underwriters exercise in full option to purchase additional shares view html  download pdf mar   insmed prices  million equity offering view html  download pdf mar   insmed incorporated announces proposed public offering of common stock view html  download pdf mar   insmed incorporated reports financial results for the fourth quarter and twelvemonths of  view html  download pdf feb   insmed to announce  fourth quarter and year end financial results thursday march  view html  download pdf feb   insmed incorporated files shelf registration statement view html  download pdf jan   u of rochester initiates phase  clinical trial of insmeds iplex for the treatment of myotonic muscular dystrophy trial funded by nih and mda grants view html  download pdf dec   fda approves insmeds orphan drug iplex for the treatment of severe primary igf deficiency the first oncedaily therapy for the treatment of severe primary ifg deficiency view html  download pdf dec   insmed responds to complaint filed by tercica view html  download pdf nov   insmed to present at the lazard capital markets life sciences conference view html  download pdf nov   insmed incorporated reports financial results for the third quarter and first nine months of  view html  download pdf nov   insmed to present at the rodman and renshaw th annual healthcare conference view html  download pdf nov   insmed to release third quarter financial results thursday november  view html  download pdf oct   fda to review insmeds complete response to approvable letter for iplex view html  download pdf oct   insmed to present at the ce unterberg towbin emerging growth life sciences conference view html  download pdf oct   insmed to present at the bio investor forum conference view html  download pdf oct   insmed submits response to fda approvable letter for iplex view html  download pdf sep   insmed provides update on iplex pivotal trial data in severe primary igf deficiency view html  download pdf sep   insmed issues statement regarding iplextm approvable letter press release view html  download pdf sep   insmed receives approvable letter for iplextm conference call tomorrow at am est view html  download pdf sep   somatokiner pivotal data to be featured in a podium presentation at the espelwpes th joint meeting of pediatric endocriniology in lyon france view html  download pdf aug   insmed incorporated reports financial results for the second quarter and first half of  view html  download pdf aug   insmed to release second quarter financial results monday august  view html  download pdf jun   fda extends pdufa date for somatokine to october   view html  download pdf may   insmed reports detailed positive results from its pivotal clinical trial of somatokine in patients with growth hormone insensitivity syndrome view html  download pdf may   insmed to present at needham  company biotechnology conference may   view html  download pdf may   insmed announces the continuation of litigation in the united kingdom judges ruling allows for the continuation of legal action in suit filed by tercica view html  download pdf may   insmed to present at ubs global pharmaceutical conference may   view html  download pdf may   insmed incorporated reports financial results for first quarter of  view html  download pdf may   insmed inc to webcast first quarter earnings conference call thursday may  at  am et view html  download pdf apr   insmed initiates phase ii trial with somatokiner in type a extreme insulin resistance view html  download pdf apr   insmed initiates phase ii hivassociated lipodystrophy trial with somatokiner view html  download pdf apr   patent infringement suit against insmed dismissed view html  download pdf apr   fda grants priority review for insmeds nda for somatokine for the treatment of growth hormone insensitivity syndrome view html  download pdf mar   insmed announces exclusive option agreement with ucsf for series of igf receptor antagonists agreement expands collaboration on igf program in prostate cancer view html  download pdf mar   insmed incorporated reports financial results for fourth quarter and twelvemonths of  view html  download pdf mar   insmed announces completion of  million financing view html  download pdf mar   insmed to release fourth quarter and year end financial results wednesday march  view html  download pdf mar   fda accepts for review insmeds nda for somatokine for the treatment of growth hormone insensitivity syndrome view html  download pdf feb   insmed provides response to united states patent lawsuit seeks immediate dismissal or summary judgment for all claims view html  download pdf feb   insmed provides response to uk patent lawsuit view html  download pdf jan   insmed submits new drug application nda to seek regulatory approval of somatokine for the treatment of growth hormone insensitivity syndrome view html  download pdf dec   insmed completes new drug application nda for somatokine for the treatment of growth hormone insensitivity syndrome conference call scheduled for  am january   view html  download pdf dec   insmed incorporated released the following statement in response to recent actions by tercica inc view html  download pdf dec   insmed incorporated released the following statement in response to a press release made yesterday by tercica inc view html  download pdf nov   insmed announces expansion of patent portfolio in the treatment of diabetes new european patent granted for somatokine view html  download pdf nov   insmed incorporated reports financial results for third quarter and first ninemonths of  view html  download pdf nov   insmed raises approximately  million in direct placement of common stock view html  download pdf oct   insmed to present at rodman and renshaw healthcare conference october   presentation to be webcast live view html  download pdf oct   insmed receives european orphan drug designation for somatokine for the treatment of extreme insulin resistance company to initiate clinial trial in type a insulin resistance view html  download pdf oct   insmed and tzamal pharma announce agreement for the promotion and distribution of somatokine in middle eastern territories view html  download pdf oct   insmed announces initiation of clinical study of small molecule igfir tyrosine kinase inhibitor view html  download pdf sep   insmed announces appointment of dr kenneth attie former genentech researcher assumes role as medical director view html  download pdf sep   insmed reports results from nine months of somatokine therapy for a patient with extreme insulin resistance at the rd meeting of the european society of pediatric endocrinology view html  download pdf sep   insmed initiates phase i clinical study for novel antitumor protein view html  download pdf aug   insmed requests halt of trading of its common stock on the berlinbremen stock exchange company also initiates short selling audit view html  download pdf jul   insmed incorporated reports financial results for second quarter and first half of  view html  download pdf jul   insmed to report second quarter financial resultswednesday july  view html  download pdf jul   insmed reports update on pivotal clinical trial with somatokine statistically significant increase in growth rate observed at six months view html  download pdf jul   insmed announces two independent presentations at the national cancer institutes th annual meeting of spore view html  download pdf jul   insmed receives authorization for reimbursement for somatokine named patient program from france and italy newly appointed chief business officer expands the named patient program view html  download pdf may   breast cancer center of excellence awarded  million department of defense grant rhigfbp selected as a candidate agent in clinical trials view html  download pdf may   insmed to present at rodman and renshaw healthcare conference may   presentation to be webcast live view html  download pdf may   insmed incorporated reports financial results for first quarter of  view html  download pdf apr   insmed incorporated to webcast first quarter earnings conference call thursday may  at  am et   am ct view html  download pdf apr   insmed acquires manufacturing facility from baxter international view html  download pdf mar   insmed to present at wells fargo securities healthcare conference presentation to be webcast live view html  download pdf mar   insmed to present at wells fargo securities healthcare conference view html  download pdf feb   insmed incorporated reports improved financial results for fourth quarter  and twelvemonths ended december   view html  download pdf feb   insmed inc to webcast fourth quarter earnings conference call wednesday february  at  am et   am ct view html  download pdf jan   insmed obtains patent rights for extreme insulin resistance from fujisawa view html  download pdf jan   university of rochester awarded  million to study efficacy of rhigfirhigfbp somatokine in the treatment of myotonic dystrophy view html  download pdf dec   insmed receives fda orphan drug designation for rhigfirhigfbp somatokine for extreme insulin resistance view html  download pdf dec   insmed presents positive data on anticancer drug candidate to san antonio breast cancer symposium view html  download pdf dec   rhigfirhigfbp somatokine found to delay the onset of type i diabetes view html  download pdf nov   insmed presents positive data on anticancer drug candidate to aacrncieortc view html  download pdf nov   insmed incorporated reports financial results for third quarter  and ninemonths ended september   view html  download pdf nov   insmed to present cancer data to cap cure the prostate cancer foundation view html  download pdf oct   insmed incorporated to webcast third quarter earnings conference call wednesday november  at  am et   am ct view html  download pdf oct   insmed to present to rodman and renshaw healthcare conference presentation to be webcast live view html  download pdf sep   insmed to offer data showing efficacy of drug candidate in breast cancer view html  download pdf sep   insmeds phase iii drug candidate to be featured in two podium presentations at european society for paediatric endocrinology view html  download pdf sep   company profile for insmed incorporated view html  download pdf jul   insmed incorporated reports improved financial results for second quarter and first half of  view html  download pdf jul   insmed incorporated to webcast second quarter earnings conference call thursday july  at  am et   am ct view html  download pdf jul   insmed inc conludes private placement led by wells fargo securities raising  million more than previously reported view html  download pdf jul   insmed reports positive data to aacr with rhigfbp in cancer view html  download pdf jul   insmed inc raises  million in private placement of common stock lead by wells fargo securities view html  download pdf jul   insmed incorporated to present positive oncology data on rhigfbp at the annual meeting of the american association of cancer reserch view html  download pdf jun   insmed launches pivotal phase iii clinical trial in ghis data analysis planned for early  view html  download pdf jun   insmed presents positive data on lead drug candidate at endocrine society annual meeting study shows advantages of companys rhigfirhigfbp in treating growth disorder view html  download pdf jun   insmed receives european orphan drug designation for rhigfirhigfbp product will have  years of market exclusivity in treatment of growth disorder view html  download pdf jun   insmed announces management reorganization ronald d gunn promoted to executive vp lewis stuart departs as vp commercial development view html  download pdf jun   insmed to present lead drug candidate at the endocrine society annual meeting view html  download pdf jun   insmed selected to present to bio  business forum presentation to be webcast live view html  download pdf jun   insmed to report positive effects of rhigfirhigfbp in adolescent subjects with type  diabetes view html  download pdf jun   insmed presents data to asco highlighting potential benefit of rhigfbp in cancer rhigfbp shown to enhance chemotherapy in models of human breast cancer view html  download pdf may   insmed to present positive cancer data to asco view html  download pdf may   insmed incorporated to present at techvest european healthcare conference view html  download pdf may   insmed regains full compliance with nasdaq national market system listing requirements view html  download pdf may   insmed incorporated announces improved financial results for first quarter  narrowing of net loss exceeds expectations cash burn rate drops sharply view html  download pdf apr   insmed incorporated to webcast first quarter earnings conference call friday may  at  am et   am ct view html  download pdf apr   insmed announces publication of investment profile full text available on corporate website view html  download pdf apr   insmed initiates named patient programme for rhigfirhigfbp an investigational drug for severe growth disorders view html  download pdf apr   insmed chairman to provide positive outlook during ceocastcoms virtual healthcare conference view html  download pdf apr   insmed announces improved performance expectations for first quarter lead product candidate prepared to enter phase iii trials view html  download pdf apr   insmed reports positive data with rhigfbp in cancer rhigfbp improves effect of standard cancer therapies rhigfbp inhibits tumor growth up to  view html  download pdf apr   insmed ceo to highlight near term commercial opportunity lead drug on track for potential fda approval in  cash expected to fund operations through potential approval view html  download pdf apr   insmed chairman and ceo provides positive outlook in special letter to shareholders view html  download pdf mar   insmed incorporated retains investor relations international as investor relations counsel company to immediately implement new shareholder communications program view html  download pdf feb   insmed incorporated reports yearend and fourth quarter financial results view html  download pdf jan   insmed reports positive effects of somatokine rhigfirhigfbp in adolescent subjects with type  diabetes view html  download pdf jan   insmed incorporated to webcast fourth quarter earnings conference call tuesday february  at  am et   am ct view html  download pdf jan   insmed incorporated appeals delisting notification from nasdaq view html  download pdf jan   insmed incorporated announces positive preclinical oncology data with rhigfbp view html  download pdf dec   insmed announces senior management changes view html  download pdf nov   insmed presents igfbp anticancer data at the international symposium on the functional role of igfbps view html  download pdf oct   insmed incorporated to webcast third quarter earnings conference call thursday october   at  am et  am ct view html  download pdf oct   insmed incorporated reports third quarter results view html  download pdf oct   insmed acquires igf regulatory files for growth hormone insensitivity syndrome from pharmacia extensive regulatory files expected to expedite commercialization of somatokine view html  download pdf sep   insmed restructures to advance most promising drug candidates and optimize resources view html  download pdf sep   insmed discontinues internal development of ins for diabetes and polycystic ovary syndrome  pcos  view html  download pdf sep   insmed announces appointment of mary callan as vice president of corporate development view html  download pdf aug   insmed announces appointment of vice president of commercial development view html  download pdf jul   insmed incorporated and avecia limited announce development and manufacturing agreement for somatokine view html  download pdf jul   insmed incorporated reports second quarter results view html  download pdf jul   insmed incorporated invites you to join its nd quarter earnings conference call on tuesday july   at  am edt view html  download pdf jul   insmed presents lead drug candidates at endo  the th annual meeting of the endocrine society view html  download pdf jul   insmed incorporated receives orphan drug designation for somatokine for the treatment of growth hormone insensitivity syndrome laron syndrome and inititates clinical study view html  download pdf jul   insmed incorporated announces investor update conference call tuesday july   at  am et   am ct view html  download pdf jun   insmed reports data on insulin sensitizing drug at american diabetes associations annual meeting view html  download pdf jun   insmed announces that data at american diabetes association annual meeting will highlight drug pipeline view html  download pdf may   insmed incorporated reports first quarter results view html  download pdf apr   insmed incorporated to webcast first quarter investor update conference call friday may   at  am et view html  download pdf feb   insmed incorporated and oxagen limited form partnership to create a genetic study of polycystic ovary syndrome view html  download pdf feb   insmed incorporated to present at wall street analyst forum view html  download pdf jan   insmed incorporated reports fourth quarter and yearend financial results view html  download pdf jan   insmed incorporated to webcast fourth quarter investor update conference call thursday january   at  am et  am ct view html  download pdf jan   insmed reports positive effects of somatokine in subjects with type  diabetes view html  download pdf jan   insmed appoints vice president of clinical development view html  download pdf you are now leaving insmeds web site insmed does not control review or endorse thirdparty web sites and you agree that insmed is not responsible for the content of the web site you are about to enter continue insmed incorporated nasdaqinsm quotes  news  google financecookies help us deliver our services by using our services you agree to our use of cookieslearn moregot itmy accountsearchmapsyoutubeplaynewsgmaildrivecalendargoogletranslatephotosmoreshoppingwalletfinancedocsbooksbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinanceinsmed incorporatednasdaqinsmadd to portfoliocompanysummarynewsoption chainrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   insmed incorporated  public nasdaqinsm   watch this stock      jul   close nasdaq realtime data  disclaimer currency in usd range     week    open  vol  avg  mkt cap b pe      divyield      eps  shares m beta  inst own  news relevance date all news for insmed incorporated » subscribe advertisement events add insm to my calendars aug   q  insmed inc earnings release estimated  am edt  jul   insmed inc analyst and investor day  jun   insmed inc at jmp securities life science conference may   insmed inc annual shareholders meeting may   insmed inc at deutsche bank health care conference  may   q  insmed inc earnings release may   q  insmed inc earnings call  more events from dailyfinance »     key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score   screen stocks with similar metrics » address  finderne ave bldg bridgewater nj united states  map phone website links httpwwwinsmedcom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector healthcare  industry bio therapeutic drugs more from factset » description insmed incorporated is a biopharmaceutical company the company operates through development and commercialization of therapies for patients with rare diseases segment its lead product candidate is arikayce or liposomal amikacin for inhalation lai which is in latestage development for adult patients with treatment refractory nontuberculous mycobacteria ntm lung disease caused by mycobacterium avium complex mac its earlierstage pipeline includes preclinical compounds that the company is evaluating in multiple rare diseases of unmet medical need including methicillinresistant staph aureus and ntm its earlier clinicalstage pipeline includes ins and ins ins is an oral reversible inhibitor of dipeptidyl peptidase  ins is an inhaled nanoparticle formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders including pulmonary arterial hypertension it has completed a phase i study of ins more from reuters » officers and directors william h lewis president chief executive officer director age  bio  compensation   reuters paolo tombesi chief financial officer age  bio  compensation   reuters orlov s nicole schaeffer senior vice president human resource and corporate services age  bio  compensation   reuters eugene jeffrey sullivan md chief product strategy officer and chief scientific officer age  bio  compensation   reuters peggy j berry vice president regulatory affairs age  bio  compensation   reuters mark quigley vice president quality assurance age  bio  compensation   reuters christine a pellizzari general counsel corporate secretary age  bio  compensation   reuters roger adsett chief commercial officer age  bio  compensation   reuters paul streck chief medical officer age  bio  compensation   reuters donald j hayden jr nonexecutive chairman of the board age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service request unsuccessful incapsula incident id  investor relations  insmed select page video player    use updown arrow keys to increase or decrease volume investor relations we are focused on developing and commercializing drugs that treat rare diseases nasdaq insm     day high  day low   volume      pm et jul   delayed  min by esignal related links management board of directors investor materials view the latest insmed investor presentation here learn more key clinical publications insmed actively publishes and presents clinical data for its product candidates learn more email alerts want to stay up to date on our news events and filings set up your email alerts sign up investor  media contacts insmed investor relations laura perry   argot partners email you are now leaving insmeds web site insmed does not control review or endorse thirdparty web sites and you agree that insmed is not responsible for the content of the web site you are about to enter continue insmed insurance agency inc  products  services home about us membership networking inbox wall import address book photo albums find other professionals other resources frequently asked questions spam whitelist instructions copyright credit logos  images the complete marketeer manage subscriptions unsubscribe from emails careers  open positions contact us manage your subscriptions consumers find it find a market exclusive consumer leads find a job find candidates find a company search blogs search users search industry articles search discussionstopics find toolsproducts insurance news jobs find a job post a job find candidates articles for candidates articles for employers talent solutions ats applicant tracking forums ask your peers agency management careers  jobs life health  fin svcs marketing property  casualty technology  tools using completemarkets groups my subscribed groups all groups manage your subscriptions manage your subscriptions education all articles search the library article categories manage your subscriptions blogs create your own blog insurance professionals insurance marketing advertisers market providers axis brokers cochrane  company colonial general insurance agency industry experts th sense proposals st century management dr jack nordhaus graham communications hr that works sound marketing inc product  service providers aged insurance leads the wedge group all blogs manage your subscriptions tools insurance newsletters jobscareers calltracking productivity tools manage your subscriptions consumers get a quote insurance categories advertise advertising solutions talent solutions demomedia kit create a free completemarkets accountlogin to completemarkets x no thanks please wait x no thanks please wait x no thanks please wait x no thanks please wait insmed insurance agency inc   reviews   of  write your review here required please consider the following  would you recommend this company  what about this company do you likedislike  why did you choose this rating submit this anonymously cancel submit write a review please authenticate first to post andor edit reviews connect connect or fill out the form below to submit the review first name last name email i am a  client peer please give star rating  highest lowest  rating field is required write your review here required please consider the following  would you recommend this company  what about this company do you likedislike  why did you choose this rating please enter text with minimum of  characters long submit this anonymously cancel submit  brook st fl  scarsdale ny   is this your company you are now following insmed insurance agency inc you are already following insmed insurance agency inc unfollow fill out the form below to follow insmed insurance agency inc first name last name email follow are you sure you want to deactivate your completemarkets company profile deactivate cancel are you looking for insurance get insurance for you your family and your business your information is secure and confidential we share your information with only one insurance expert the agent in our network that can help you we use a patent pending process designed to get you the best dervice available get a quote   are you an insurance professional find insurance markets content leads and tools exclusive insurance leads easy submissions to wholesalers fine specialty insurance markets powerful microsites that drive seo traffic get a quote   please wait about usproductsservicesjobsteamarticlesbloggroupfollowersphotosreviews auto insurance in scarsdale ny  brook st fl  scarsdale ny  request a quote now business insurance in scarsdale ny  brook st fl  scarsdale ny  request a quote now home owners insurance in scarsdale ny  brook st fl  scarsdale ny  request a quote now x no thanks please wait you have already requested approval to this storefront please wait  hours before requesting again oops looks like you hit the maximum amount of new storefronts interested in more contact us are you looking for insurance get insurance for you your family and your business your information is secure and confidential we share your information with only one insurance expert the agent in our network that can help you we use a patent pending process designed to get you the best dervice available get a quote   are you an insurance professional find insurance markets content leads and tools exclusive insurance leads easy submissions to wholesalers fine specialty insurance markets powerful microsites that drive seo traffic get a quote   please wait site membership click here to log in no account register here home about us privacy policy terms of use user content agreement copyright compliance policy contact us insurance pros leverage completemarkets get a custom url feedback articles find it markets  products  services blogs  groups other professionals breaking advertiser news jobscareers networking inbox import address book import linkedin contacts blogs groups discussions photo albums advertisers why completemarkets get a custom url testimonials resources frequently asked questions insuranceservice providers storefronts spam whitelist instructions copyright  all rights reserved insomis corp microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft insmed insm  stock predictions  price targets facebook autocomplete demo post a rating  month price target   home trending sign up log in insmed inc insm median target price   upside positive ratings  of  analysts latest  robert w baird  outperform     view all analyst ratings for insm » facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising flashratings  privacy facebook autocomplete demo post a rating  month price target   trending sign up log in privacy flashratings takes the privacy of its users seriously we are committed to safeguarding the privacy of our users while providing a personalised and valuable service this privacy policy statement explains the data processing practices of flashratingscom if you have any requests concerning your personal information or any queries with regard to these practices please contact us here  flashratings collects personal information when you register or when you provide such information voluntarily  we use cookies and other technologies to find out how you use flashratings  flashratings accesses information automatically when you visit our site this information includes url ipaddress browsertype language as well as date and time of your visit  we dont pass on personal information to any third party beyond other flashratings users as specified above without your explicit approval  only summarized depersonalized information is provided to third parties  personal information is used for providing services requested by the user including services with personalized content  additionally we use your personal information for internal research in order to improve your online experience as well as our technologies and services terms of use by using this website you agree to the following terms of use the content on this site including news quotes data and other information is provided by flashratings inc and its third party content providers for your personal information only and is not intended for trading purposes content on this site is not appropriate for the purposes of making a decision to carry out a transaction or trade nor does it provide any form of advice investment tax legal amounting to investment advice or make any recommendations regarding particular financial instruments investments or products neither flashratings inc nor its third party content providers shall be liable for any errors inaccuracies or delays in content or for any actions taken in reliance thereon flashratings inc expressly disclaims all warranties expressed or implied as to the accuracy of any the content provided or as to the fitness of the information for any purpose although flashratings inc makes reasonable efforts to obtain reliable content from third parties flashratings inc does not guarantee the accuracy of or endorse the views or opinions given by any third party content provider this site may point to other internet sites that may be of interest to you however flashratings inc does not endorse or take responsibility for the content on such other sites inc insmed  wowcom  web results aol search skip over navigation search the web web images images reference reference inc at macys  shop inc international concepts ad · macyscom​inc shop inc international concepts save on the seasons latest trends  l lee jackson memorial hwy fairfax ·  directions  ·   macyscom is rated rated  out of   reviews mens clothes plus size clothes activewear womens clothes juniors clothes kids clothes insm stock predictions  flashratingscom ad · flashratingscom all current analyst ratings and price targets for insmed about us flashratings principles analyst ranking privacy grandma’s income secret  tradewinscom ad · wwwtradewinscom grandma’s simple secret for extra income for small investors searches related toinc insmed insmed pharmaceuticals insmed news insmed stock insmed pharmaceuticals linkedin insmed incorporated careers insm message board insmed investor relations insmed corporation web results insmed  powered by purpose wwwinsmedcom about us insmed is dedicated to improving the lives of patients battling serious and rare diseases our mission is to develop novel transformational therapies that  careers company pipeline about arikayce about ntm lung infections contact us insm stock price  insmed inc stock quote us nasdaq  wwwmarketwatchcominvestingstockinsm insmed inc stock price stock quotes and financial overviews from marketwatch insmed incorporated nasdaqinsm quotes  news  google  wwwgooglecomfinancecid get detailed financial information on insmed incorporated nasdaqinsm including realtime stock quotes historical charts  financial news all for free investor relations  insmed investorinsmedcom the investor relations website contains information about insmed incorporated business for stockholders potential investors and financial analysts insm  summary for insmed inc  yahoo finance httpsfinanceyahoocomquoteinsm view the basic insm stock chart on yahoo finance change the date range chart type and compare insmed inc against other companies insmed company profile  owler httpswwwowlercomiaappinsmedcompanyprofile insmed has  employees and an estimated annual revenue of m check out insmeds profile for competitors acquisition history news and more insm stock quote  insmed inc common stock price  wwwnasdaqcomsymbolinsm stock quote for insmed inc common stock insm  get realtime last sale and extended hours stock prices company news charts and companyspecific research tools  insmed incorporated  linkedin httpswwwlinkedincomcompanyinsmed learn about working at insmed incorporated join linkedin today for free see who you know at insmed incorporated leverage your professional network and get hired welcome to insmed httpswwwinsmedinsurancecom the insmed insurance agency inc is an independent insurance firm that specializes in working with healthcare institutions and professionals in identifying  inc at macys  shop inc international concepts ad · macyscom​inc shop inc international concepts save on the seasons latest trends  l lee jackson memorial hwy fairfax ·  directions  ·   macyscom is rated rated  out of   reviews mens clothes plus size clothes activewear womens clothes juniors clothes kids clothes insm stock predictions  flashratingscom ad · flashratingscom all current analyst ratings and price targets for insmed about us flashratings principles analyst ranking privacy grandma’s income secret  tradewinscom ad · wwwtradewinscom grandma’s simple secret for extra income for small investors searches related toinc insmed insmed pharmaceuticals insmed news insmed stock insmed pharmaceuticals linkedin insmed incorporated careers insm message board insmed investor relations insmed corporation next search the web  aol inc all rights reservedprivacy   terms of use   about our ads   preferences   contact us   powered by bing™ part of the aol search network insmed  powered by purpose insmed  powered by purpose select page powered by purposeour commitment to transforming the lives of people with rare diseases drives what we doabout usinsmed is dedicated to improving the lives of patients battling serious and rare diseases our mission is to develop novel transformational therapies that make a real difference to patients learn morewill lewispresident and chief executive officerread full biopaolo tombesichief financial officerread full biopaul streck mdchief medical officerread full bioroger adsettchief commercial officerread full biochristine pellizzarigeneral counsel  corporate secretaryread full bionicole schaeffersenior vice president human resources and corporate servicesread full bioeugene sullivan mdchief product strategy officerread full biowalter perkins phdchief technology officerread full biowade kingsenior vice president corporate development  strategy corporate developmentread full biocareers view jobsinvestor relations view corporate presentation“my model for business is the beatles they were four guys who kept each other’s kind of negative tendencies in check they balanced each other and the total was greater than the sum of the parts that’s how i see business great things in business are never done by one person they’re done by a team of people”– steve jobs you are now leaving insmed’s web siteinsmed does not control review or endorse thirdparty web sites and you agree that insmed is not responsible for the content of the web site you are about to entercontinue bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one